Cancer Commons

Cancer Commons Nonprofit empowering advanced cancer patients with information they need for best-possible outcomes.

Our Founder:

Marty Tenenbaum is a renowned computer scientist and cancer warrior. After surviving stage IV melanoma, he set out to create a ‘commons’ to ensure that all cancer patients are treated according to the latest scientific and clinical knowledge. The information on or available through Cancer Commons' page is intended for educational purposes only. Cancer Commons does not repres

ent or guarantee that information on or available through its page is applicable to any specific patient’s care or treatment. The educational content on or available through Cancer Commons' page does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Cancer Commons recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through Cancer Commons' page might apply to their individual treatment or care.

Here’s the latest from our Curious Dr. George! Read "The Strong Helping Hand of Cancer Commons" here: bit.ly/CCCDGBakker...
06/17/2026

Here’s the latest from our Curious Dr. George! Read "The Strong Helping Hand of Cancer Commons" here: bit.ly/CCCDGBakker

Cancer is frequently accompanied by psychological distress and mental health challenges that are often neglected. Our Curious Dr. George asks Unsha Bakker, MSN, RN, OCN, CBCN, Cancer Commons Oncology Nurse Navigator for the Brain Cancer Support and Solutions Alliance (BCSSA), for her perspective on these issues—and how Cancer Commons can help.

BCSSA is a collaboration between Head For The Cure, the Musella Foundation For Brain Tumor Research & Information, Inc., and Cancer Commons. Our Nurse Navigator program is made possible through generous grant support provided by Head for the Cure and the Musella Foundation.

For 𝗕𝗿𝗮𝗶𝗻 𝗧𝘂𝗺𝗼𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵, you're invited to a free webinar: 𝗛𝗮𝗿𝗻𝗲𝘀𝘀𝗶𝗻𝗴 𝗢𝘅𝘆𝗴𝗲𝗻 𝘁𝗼 𝗙𝗶𝗴𝗵𝘁 𝗕𝗿𝗮𝗶𝗻 𝗧𝘂𝗺𝗼𝗿𝘀 | TODAY Tuesd...
05/12/2026

For 𝗕𝗿𝗮𝗶𝗻 𝗧𝘂𝗺𝗼𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵, you're invited to a free webinar: 𝗛𝗮𝗿𝗻𝗲𝘀𝘀𝗶𝗻𝗴 𝗢𝘅𝘆𝗴𝗲𝗻 𝘁𝗼 𝗙𝗶𝗴𝗵𝘁 𝗕𝗿𝗮𝗶𝗻 𝗧𝘂𝗺𝗼𝗿𝘀 | TODAY Tuesday, May 12 at 4pm PT | 7pm ET

Tumor hypoxia (low oxygen in the tumor environment) is a key factor in glioblastoma's resistance to treatment. This webinar explores emerging approaches to reversing hypoxia and improving the efficacy of standard of care, featuring Dr. Nicholas Blondin of Yale Medicine.

Presented by our longtime partner, the Musella Foundation For Brain Tumor Research & Information, Inc. Link to attend: virtualtrials.org/webinar

We are honored to celebrate   and share this wonderful post from our partner Head For The Cure. Sending gratitude every ...
05/06/2026

We are honored to celebrate and share this wonderful post from our partner Head For The Cure. Sending gratitude every day to 𝗨𝗻𝘀𝗵𝗮 𝗕𝗮𝗸𝗸𝗲𝗿, 𝗠𝗦𝗡, 𝗥𝗡, 𝗢𝗖𝗡, 𝗖𝗕𝗖𝗡, Brain Cancer Support and Solutions Alliance Nurse Navigator at Cancer Commons.

For National Nurses Day, we are proud to feature Unsha Bakker, MSN, RN, OCN, CBCN, our Brain Cancer Support and Solutions Alliance (BCSSA) Nurse Navigator.

In collaboration with Head for the Cure, the Musella Foundation For Brain Tumor Research & Information, Inc, and Cancer Commons, Unsha plays a pivotal role in supporting the brain tumor community. With over a decade of nursing experience, she brings both expertise and compassion to help patients navigate a brain tumor diagnosis.

“I have found my calling in oncology nursing. This field has deeply impacted me and has opened my heart tenfold. The patients and loved ones I interact with each day have brought new meaning to my life,” Unsha shares.

Learn more about Unsha and our work with the BCSSA:
https://www.cancercommons.org/bcssa

Here’s the latest from our Curious Dr. George! Read Cancer Commons “Seeking Patients with Advanced Cancer for a New Clin...
04/28/2026

Here’s the latest from our Curious Dr. George! Read Cancer Commons “Seeking Patients with Advanced Cancer for a New Clinical Study” here: bit.ly/CCCDGPillai

Cancer Commons has launched a new clinical study that features drug sensitivity testing—laboratory testing of individual patients’ cancer cells to identify drugs that might work for them. Our Curious Dr. George asks Cancer Commons Director of Clinical Sciences Prajit Pillai, PhD, MBA, about the study.

Address

2625 Middlefield Road Ste 104
Palo Alto, CA
94306

Alerts

Be the first to know and let us send you an email when Cancer Commons posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cancer Commons:

Share